Implication of intracellular localization of transcriptional repressor PLZF in thyroid neoplasms

BMC Endocrine Disorders

Volumn 14, Issue , 2014, Pages

  Matsuzawa, Kazuhiko ^a   Izawa, Shoichiro ^a   Ohkura, Tsuyoshi ^a   Ohkura, Hiroko ^a   Ishiguro, Kiyosuke ^a   Yoshida, Akio ^b   Takiyama, Yumi ^c   Haneda, Masakazu ^c   Shigemasa, Chiaki ^d   Yamamoto, Kazuhiro ^a   Taniguchi, Shin ichi ^a  

^a TOTTORI UNIVERSITY   (Japan)

^b TOTTORI UNIVERSITY   (Japan)

^c ASAHIKAWA MEDICAL COLLEGE   (Japan)

^d Tottori Municipal Hospital   (Japan)

Author keywords

Localization; Lymph node metastasis; PLZF; Thyroid carcinoma; Tumourigenesis

Indexed keywords

PROMYELOCYTIC LEUKAEMIA ZINC FINGER PROTEIN; UNCLASSIFIED DRUG; ZINC FINGER PROTEIN; KRUPPEL LIKE FACTOR; ZBTB16 PROTEIN, HUMAN;

ADENOMA; ADULT; AGED; ARTICLE; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CYTOSOL; FEMALE; FOLLICULAR ADENOMA; GENE EXPRESSION PROFILING; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; PROMYELOCYTIC LEUKAEMIA ZINC FINGER GENE; PROTEIN EXPRESSION; REPRESSOR GENE; THYROID ADENOMATOUS LESION; THYROID CARCINOMA; THYROID TUMOR; WESTERN BLOTTING; CANCER STAGING; CELL NUCLEUS; COMPARATIVE STUDY; CYTOPLASM; ENZYME IMMUNOASSAY; METABOLISM; MIDDLE AGED; PAPILLARY CARCINOMA; PATHOLOGY; PROGNOSIS; SECONDARY; THYROID GLAND; TUMOR INVASION;

ADENOMA; ADULT; AGED; BLOTTING, WESTERN; CARCINOMA, PAPILLARY; CELL NUCLEUS; CYTOPLASM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; PROGNOSIS; THYROID GLAND; THYROID NEOPLASMS;

EID: 84904420156     PISSN: None     EISSN: 14726823     Source Type: Journal    
DOI: 10.1186/1472-6823-14-52     Document Type: Article

References (19)

1. Davies L, Welch HG. Increasing incidence of thyroid cancer in the United States, 1973-2002. JAMA 2006, 295:2164-2167. 10.1001/jama.295.18.2164, 16684987.
2. Leenhardt L, Grosclaude P, Chérié-Challine L. Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee. Thyroid 2004, 14:1056-1060. 10.1089/thy.2004.14.1056, 15650358.
3. Pilli T, Prasad KV, Jayarama S, Pacini F, Prabhakar BS. Potential utility and limitations of thyroid cancer cell lines as models for studying thyroid cancer. Thyroid 2009, 19:1333-1342. 10.1089/thy.2009.0195, 2833173, 20001716.
4. Chen Z, Brand NJ, Chen A, Chen SJ, Tong JH, Wang ZY, Waxman S, Zelent A. Fusion between a novel Krüppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(11;17) translocation associated with acute promyelocytic leukaemia. EMBO J 1993, 12:1161-1167. 413318, 8384553.
5. Chen SJ, Zelent A, Tong JH, Yu HQ, Wang ZY, Derrè J, Berger R, Waxman S, Chen Z. Rearrangements of the retinoic acid receptor alpha and promyelocytic leukemia zinc finger genes resulting from t(11;17)(q23;q21) in a patient with acute promyelocytic leukemia. J Clin Invest 1993, 91:2260-2267. 10.1172/JCI116453, 288229, 8387545.
6. Li JY, English MA, Ball HJ, Yeyati PL, Waxman S, Licht JD. Sequence-specific DNA binding and transcriptional regulation by the promyelocytic leukemia zinc finger protein. J Biol Chem 1997, 272:22447-22455. 10.1074/jbc.272.36.22447, 9278395.
7. Felicetti F, Bottero L, Felli N, Mattia G, Labbaye C, Alvino E, Peschle C, Colombo MP, Carè A. Role of PLZF in melanoma progression. Oncogene 2004, 23:4567-4576. 10.1038/sj.onc.1207597, 15077196.
8. Cheung M, Pei J, Pei Y, Jhanwar SC, Pass HI, Testa JR. The promyelocytic leukemia zinc-finger gene, PLZF, is frequently downregulated in malignant mesothelioma cells and contributes to cell survival. Oncogene 2010, 29:1633-1640. 10.1038/onc.2009.455, 2842080, 20010871.
9. McConnell MJ, Chevallier N, Berkofsky-Fessler W, Giltnane JM, Malani RB, Staudt LM, Licht JD. Growth suppression by acute promyelocytic leukemia-associated protein PLZF is mediated by repression of c-myc expression. Mol Cell Biol 2003, 23:9375-9388. 10.1128/MCB.23.24.9375-9388.2003, 309637, 14645547.
10. Allred DC, Harvey JM, Berardo M, Clark GM. Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 1998, 11:155-168.
11. Zhang T, Xiong H, Kan LX, Zhang CK, Jiao XF, Fu G, Zhang QH, Lu L, Tong JH, Gu BW, Yu M, Liu JX, Licht J, Waxman S, Zelent A, Chen E, Chen SJ. Genomic sequence, structural organization, molecular evolution, and aberrant rearrangement of promyelocytic leukemia zinc finger gene. Proc Natl Acad Sci U S A 1999, 96:11422-11427. 10.1073/pnas.96.20.11422, 18049, 10500192.
12. Shaknovich R, Yeyati PL, Ivins S, Melnick A, Lempert C, Waxman S, Zelent A, Licht JD. The promyelocytic leukemia zinc finger protein affects myeloid cell growth, differentiation, and apoptosis. Mol Cell Biol 1998, 18:5533-5545. 109138, 9710637.
13. Ward JO, McConnell MJ, Carlile GW, Pandolfi PP, Licht JD, Freedman LP. The acute promyelocytic leukemia-associated protein, promyelocytic leukemia zinc finger, regulates 1,25-dihydroxyvitamin D(3)-induced monocytic differentiation of U937 cells through a physical interaction with vitamin D(3) receptor. Blood 2001, 98:3290-3300. 10.1182/blood.V98.12.3290, 11719366.
14. Yeyati PL, Shaknovich R, Boterashvili S, Li J, Ball HJ, Waxman S, Nason-Burchenal K, Dmitrovsky E, Zelent A, Licht JD. Leukemia translocation protein PLZF inhibits cell growth and expression of cyclin A. Oncogene 1999, 18:925-934. 10.1038/sj.onc.1202375, 10023668.
15. Doulatov S, Notta F, Rice KL, Howell L, Zelent A, Licht JD, Dick JE. PLZF is a regulator of homeostatic and cytokine-induced myeloid development. Genes Dev 2009, 23:2076-2087. 10.1101/gad.1788109, 2751973, 19723763.
16. Nanba D, Mammoto A, Hashimoto K, Higashiyama S. Proteolytic release of the carboxy-terminal fragment or proHB-EGF causes nuclear export of PLZF. J Cell Biol 2003, 163:489-502. 10.1083/jcb.200303017, 2173632, 14597771.
17. Ota I, Higashiyama S, Masui T, Yane K, Hosoi H, Matsuura N. Heparin-binding EGF-like growth factor enhances the activity of invasion and metastasis in thyroid cancer cells. Oncol Rep 2013, 30:1593-1600. 3810215, 23917679.
18. Felli N, Flicetti F, Lustri AM, Errico MC, Bottero L, Cannistraci A, De Feo A, Petrini M, Pedini F, Biffoni M, Alvino E, Negrini M, Ferracin M, Matta G, Carè A. miR-126 and 126* restored expressions play a tumor suppressor role by directly regulating ADAM9 and MMP7 in melanoma. PLoS One 2013, 8:e56824. 10.1371/journal.pone.0056824, 3578857, 23437250.
19. Ozeki K, Tanida S, Morimoto C, Inoue Y, Mizoshita T, Tsukamoto H, Shimura T, Kataoka H, Kamiya T, Nishiwaki E, Ishiguro H, Higashiyama S, Joh T. Telmisartan inhibits cell proliferation by blocking nuclear translocation of ProHB-EGF C-terminal fragment in colon cancer cells. PLoS One 2013, 8:e56770. 10.1371/journal.pone.0056770, 3579940, 23451083.